Citation: Wf. Sullivan, SECURING RELIGIOUS-LIBERTY - PRINCIPLES FOR JUDICIAL INTERPRETATION OF THE RELIGION CLAUSES - CHOPER,JH, The Journal of religion, 77(2), 1997, pp. 327-328
Citation: Wf. Sullivan, FOREORDAINED FAILURE - THE QUEST FOR A CONSTITUTIONAL PRINCIPLE OF RELIGIOUS FREEDOM - SMITH,SD, Church history, 66(3), 1997, pp. 666-668
Citation: Wf. Sullivan, RELIGION, LAW AND THE CONSTRUCTION OF IDENTITIES - INTRODUCTION( CONSIDERATIONS ON THE MODERN LEGAL DISESTABLISHMENT OF RELIGION IN SECULARSOCIETY ), Numen, 43(2), 1996, pp. 128-138
Citation: Wf. Sullivan, COMPETING THEORIES OF RELIGION AND LAW IN THE SUPREME-COURT OF THE UNITED-STATES -AMENDMENT JURISPRUDENCE - AN HASIDIC CASE( EXPLORING THE CLASH OF THEOLOGIES AND CONSTITUTIONAL THEORIES REGARDING FIRST), Numen, 43(2), 1996, pp. 184-212
Authors:
MORELAND LW
SEWELL KL
TRENTHAM DE
BUCY RP
SULLIVAN WF
SCHROHENLOHER RE
SHMERLING RH
PARKER KC
SWARTZ WG
WOODWORTH TG
KOOPMAN WJ
Citation: Lw. Moreland et al., INTERLEUKIN-2 DIPHTHERIA FUSION PROTEIN (DAB(486)IL-2) IN REFRACTORY RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION, Arthritis and rheumatism, 38(9), 1995, pp. 1177-1186
Citation: Be. Chipps et al., INTERFERON-ALPHA-2A FOR TREATMENT OF BRONCHIOLITIS CAUSED BY RESPIRATORY SYNCYTIAL VIRUS, The Pediatric infectious disease journal, 12(8), 1993, pp. 653-658
Authors:
MORELAND LW
SEWELL KL
SULLIVAN WF
SHMERLING RH
PARKER KC
SWARTZ WG
WOODWORTH TG
TRENTHAM DE
KOOPMAN WJ
Citation: Lw. Moreland et al., DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-II TRIAL OF DIPHTHERIA-INTERLEUKIN-2 FUSION TOXIN (DAB486IL-2) IN PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 36(9), 1993, pp. 190000039-190000039
Citation: Lw. Moreland et al., TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH DAB(486)IL-2 FUSIONTOXIN - DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Arthritis and rheumatism, 36(5), 1993, pp. 24-24
Authors:
SEWELL KL
MORELAND LW
SULLIVAN WF
SHMERLING RH
PARKER KC
SWARTZ WG
WOODWORTH TG
KOOPMAN WJ
TRENTHAM DE
Citation: Kl. Sewell et al., DAB(486)IL-2 IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL CONTINUATION, Arthritis and rheumatism, 36(5), 1993, pp. 31-31